Back to Trades
Welch Stephen Andrew
EVP & Head of Spec GenericsCIK 0001944355
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025
Welch Stephen Andrew, EVP & Head of Spec Generics, has filed 2 reports across 1 company, totaling $0 in disclosed volume. Purchases and sales are approximately balanced. All data sourced from SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Nov 12 | NONE Keenova Therapeutics plc | Welch Stephen Andrew | EVP & Head of Spec Generics | Other | $0 |
| Aug 4 | NONE Mallinckrodt plc | Welch Stephen Andrew | EVP & Head of Spec Generics | Other | $0 |
2 filings